,MCP-1Ser246ILK,怀

Upendra Kumar Soni1, Rupal Tripathi1,2, Pushplata Sankhwar3

  • 1Endocrinology Division, CSIR-Central Drug Research Institute, Lucknow, India.

PubMed
概括

单细胞化学吸引蛋白1 (MCP-1) 激活整合因相关激酶 (ILK),促进子宫内膜异位症的进展. 用化合物22抑制ILK抑制了小鼠模型中的病变发育和炎症,表明ILK是治疗点.